Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Background: Catheter ablation has become a well-established indication for long-term rhythm control in atrial fibrillation (AF) patients refractory to anti-arrhythmic drugs (AADs). Efficacy and safety of AF catheter ablation (AFCA) before AADs failure are, instead, questioned.Objective: The aim of t...
Main Authors: | Andrea Saglietto, Fiorenzo Gaita, Roberto De Ponti, Gaetano Maria De Ferrari, Matteo Anselmino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.664647/full |
Similar Items
-
Resource use and clinical outcomes in patients with atrial fibrillation with ablation versus antiarrhythmic drug treatment
by: Julian W. E. Jarman, et al.
Published: (2018-11-01) -
A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting
by: Xin Du, et al.
Published: (2017-07-01) -
Catheter Ablation for Atrial Fibrillation
by: Andre J. Gauri, et al.
Published: (2003-10-01) -
Review of the 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation—What Has Changed and How Does This Affect Daily Practice
by: Johanna B. Tonko, et al.
Published: (2021-08-01) -
A novel individualized strategy for cryoballoon catheter ablation in patients with paroxysmal atrial fibrillation
by: Jun Ding, et al.
Published: (2019-12-01)